3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER

Compounds of formula (I)processes for their production and their use as pharmaceuticals.

Saved in:
Bibliographic Details
Main Authors SÜLZLE, Detlev, MÖNNING, Ursula, SIEGEL, Stephan, SCHRÖDER, Jens, BÖMER, Ulf, KAPLAN, Bethany, SIEGEL, Franziska, SCHULZE, Volker, KORR, Daniel, NIEHUES, Michael, MORTIER, Jeremie Xavier G, GREULICH, Heidi, BERGER, Markus, MEYERSON, Matthew
Format Patent
LanguageEnglish
Published 02.03.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

Abstract Compounds of formula (I)processes for their production and their use as pharmaceuticals.
AbstractList Compounds of formula (I)processes for their production and their use as pharmaceuticals.
Author BÖMER, Ulf
SÜLZLE, Detlev
SCHRÖDER, Jens
NIEHUES, Michael
MÖNNING, Ursula
KORR, Daniel
KAPLAN, Bethany
SCHULZE, Volker
MEYERSON, Matthew
BERGER, Markus
GREULICH, Heidi
SIEGEL, Stephan
SIEGEL, Franziska
MORTIER, Jeremie Xavier G
Author_xml – fullname: SÜLZLE, Detlev
– fullname: MÖNNING, Ursula
– fullname: SIEGEL, Stephan
– fullname: SCHRÖDER, Jens
– fullname: BÖMER, Ulf
– fullname: KAPLAN, Bethany
– fullname: SIEGEL, Franziska
– fullname: SCHULZE, Volker
– fullname: KORR, Daniel
– fullname: NIEHUES, Michael
– fullname: MORTIER, Jeremie Xavier G
– fullname: GREULICH, Heidi
– fullname: BERGER, Markus
– fullname: MEYERSON, Matthew
BookMark eNqNi01Lw0AQQHPQg1__YaCXChlos7HW45pM3MF0p0ymxVBKKbKeJC3Uv-L_VUHw6unx4L3L7Gw4DOki-3Q49pFbjnKLBW6-1aFvn-Wlx2WvXHPEEvt2i9P8Lp_l92hk6kNfq2AZfhqVVjYuL7Da_h0SCWpSXnvjNXXgO6CnRoFj4Ec20Q4aUbBAYEreFhQNpIHKx4r0Ojt_27-f0s0vr7JRQ1YFTMfDLp2O-9c0pI_dqismhZvMyoe581P3v-oLQRFDWA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID US2023064983A1
GroupedDBID EVB
ID FETCH-epo_espacenet_US2023064983A13
IEDL.DBID EVB
IngestDate Fri Jul 19 14:41:37 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_US2023064983A13
Notes Application Number: US202217934553
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230302&DB=EPODOC&CC=US&NR=2023064983A1
ParticipantIDs epo_espacenet_US2023064983A1
PublicationCentury 2000
PublicationDate 20230302
PublicationDateYYYYMMDD 2023-03-02
PublicationDate_xml – month: 03
  year: 2023
  text: 20230302
  day: 02
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies The Broad Institute, Inc
Bayer Aktiengesellschaft
Dana-Farber Cancer Institute, Inc
RelatedCompanies_xml – name: The Broad Institute, Inc
– name: Dana-Farber Cancer Institute, Inc
– name: Bayer Aktiengesellschaft
Score 3.4509106
Snippet Compounds of formula (I)processes for their production and their use as pharmaceuticals.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Title 3-(ANILINO)-2-[3-(3-ALKOXY-PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES AS EGFR INHIBITORS FOR THE TREATMENT OF CANCER
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230302&DB=EPODOC&locale=&CC=US&NR=2023064983A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fT8IwEG8IGvVNUeMfNE00RBMaYR0bPBAzts5NYSVdISyEkHVsiYkBIhg_id_XboLwxFvbay9pm-vvrr27AnCv67Wwmig60qKKiiReJyhUojqKxCRUhUTgUKTByR1Pc3rq66A2yIGPdSxMlif0O0uOKCUqkvK-zM7r-eYSy8p8KxdP4l02zZ5t3rRKK-tY6tO4opSsVpN0qUXNkmk2e37JY380TW3UsSFtpT2pSOupPJB-K41LmW-Din0M9ruS33R5AnLxtAAOzfXfawVw0Fk9ecviSvoWp-AHowfDc9uuRx-RgoayipHRfqODAHUD5lquh1QUtEeoWq6VtbKOOOHMcAKLUaQ6aR9G23SIywoyR5sR1CPQkgZd3-Bun_jQ8CF5sRl0PcdtuZwyH0pbEXKHQM6IwdP8_5Da0Ew_tmFn4M4m3HSQnN_4fznHPX97MfA5yE9n0_gCQDFJrzVFFcehBG6BwySZNJKawEkjEo1YXILiLk5Xu8nX4CitZv5bShHkl59f8Y0E9KW4zfbhF5MgmH8
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwEA9DRX3zEz-mBpShsKBrutU9DOna1NZ1zUizsSFjNF0LgmxDJ_4l_r9e66Y-7S3JJYFcuPzuktwdQleGUY0qqWaQWnynE8DrlERafE9iNY50BQgcqcw5uR3U3K7-1K_2C-h16QuTxwn9zIMjgkTFIO_z_Lye_V1i2fnfyvdb9QJN0wdHNuzSwjoGfZreaSW72WAdbnOrZFmNblgKxA-tptfvqQm20joo2UYmD6zXzPxSZv9BxdlBGx2YbzLfRYVksoe2rGXutT202V48eUNxIX3v--iLkmsz8Hwv4DdEI89QpcT0W7w_IJ2B8GwvIDoZ-ENSKVfLtbJBJJPCdAe24ER3sz6C-_yZljViDf9G8IBhGwy6nim9HguxGWL26AjsBa7X9CQXIQZbEUuXYSmYKbP4_5g72MoS24gDdOkwabkE1jf6ZeeoG_5nBj1Ea5PpJDlCWI2za01VoUkEwK1olKbjelpVNK3Hqp6oY1RcNdPJavIF2nJl2x8Bk1qnaDsj5X-5tCJam799JGcA7nN1nu_JN-kDm3I
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=3-%28ANILINO%29-2-%5B3-%283-ALKOXY-PYRIDIN-4-YL%5D-1%2C5%2C6%2C7-TETRAHYDRO-4H-PYRROLO%5B3%2C2-C%5DPYRIDIN-4-ONE+DERIVATIVES+AS+EGFR+INHIBITORS+FOR+THE+TREATMENT+OF+CANCER&rft.inventor=S%C3%9CLZLE%2C+Detlev&rft.inventor=M%C3%96NNING%2C+Ursula&rft.inventor=SIEGEL%2C+Stephan&rft.inventor=SCHR%C3%96DER%2C+Jens&rft.inventor=B%C3%96MER%2C+Ulf&rft.inventor=KAPLAN%2C+Bethany&rft.inventor=SIEGEL%2C+Franziska&rft.inventor=SCHULZE%2C+Volker&rft.inventor=KORR%2C+Daniel&rft.inventor=NIEHUES%2C+Michael&rft.inventor=MORTIER%2C+Jeremie+Xavier+G&rft.inventor=GREULICH%2C+Heidi&rft.inventor=BERGER%2C+Markus&rft.inventor=MEYERSON%2C+Matthew&rft.date=2023-03-02&rft.externalDBID=A1&rft.externalDocID=US2023064983A1